Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul 15;11(7):1823-6.
doi: 10.1021/acschembio.6b00295. Epub 2016 Jun 3.

Elucidation of the Teixobactin Pharmacophore

Affiliations

Elucidation of the Teixobactin Pharmacophore

Hyunjun Yang et al. ACS Chem Biol. .

Abstract

This paper elucidates the teixobactin pharmacophore by comparing the arginine analogue of teixobactin Arg10-teixobactin to seven homologues with varying structure and stereochemistry. The roles of the guanidinium group at position 10, the stereochemistry of the macrolactone ring, and the "tail" comprising residues 1-5 are investigated. The guanidinium group is not necessary for activity; Lys10-teixobactin is more active than Arg10-teixobactin against Gram-positive bacteria in minimum inhibitory concentration (MIC) assays. The relative stereochemistry of the macrolactone ring is important. Diastereomer l-Thr8,Arg10-teixobactin is inactive, and diastereomer d-allo-Ile11,Arg10-teixobactin is less active. The macrolactone ring is critical; seco-Arg10-teixobactin is inactive. The absolute stereochemistry is not important; the enantiomer ent-Arg10-teixobactin is comparable in activity. The hydrophobic N-terminal tail is important. Truncation of residues 1-5 results in loss of activity, and replacement of residues 1-5 with a dodecanoyl group partially restores activity. These findings pave the way for developing simpler homologues of teixobactin with enhanced pharmacological properties.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of teixobactin and Arg10-teixobactin.
Figure 2
Figure 2
Structures of teixobactin homologues.
Scheme 1
Scheme 1
Synthesis of Arg10-teixobactin.

References

    1. Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schäberle TF, Hughes DE, Epstein S, Jones M, Lazarides L, Steadman VA, Cohen DR, Felix CR, Fetterman KA, Millett WP, Nitti AG, Zullo AM, Chen C, Lewis K. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517:455–459. - PMC - PubMed
    1. Editorial. Listen up, (2015) Nature. 517:121. - PubMed
    1. Ledford H. Promising antibiotic discovered in microbial ‘dark matter’. [accessed January 7, 2015];Nature News. 2015 Jan 7; [Online], http://www.nature.com/news/promising-antibiotic-discovered-in-microbial-....
    1. Wright G. Antibiotics: An irresistible newcomer. Nature. 2015;517:442–444. - PubMed
    1. Kahrstrom CT. Antibacterial drugs: a new drug for resistant bugs. Nature Rev. Drug Discov. 2015;14:94. - PubMed

Publication types

MeSH terms